The team at Health Outcomes Solutions has significant experience preparing manuscripts for peer-reviewed journals and presenting at medical and scientific conferences. Some recent publications and presentations are presented below.
Mathias SD, Crosby RD, Qian Y, Jiang Q, Dansey R, Chung K. Estimating Minimally Important Differences (MID) for the Worst Pain Rating of the Brief Pain Inventory-Short Form. J of Support Oncol; 2011; 9:72-78.
Crosby RD, Mathias SD, Marshall TS. Relationships between symptoms, symptom bother and health-related quality of life in patients with overactive bladder taking solifenacin or placebo in the VIBRANT study. Int J of Clin Prac; 2011; 65(2):211-218.
Sanz MA, Aledort L, Mathias SD, Wang X, Isitt JJ. Analysis of EQ-5D Scores from Two Phase 3 Clinical Trials of Romiplostim in the Treatment of Immune Thrombocytopenia (ITP). Value in Health; 2011; 14:90-96.
Mathias SD, Dreskin SC, Kaplan A, Saini SS, Spector S, Rosen KE. Development of an Urticaria Patient Diary for Chronic Idiopathic Urticaria. Ann of Allergy, Asthma and Immunol; 2010; 105: 142-148.
Colwell HH, Mathias SD, Turner MP, Lu J, Devercelli G, Wright N, Peeters M, Cella DF. Psychometric evaluation of the FACT Colorectal Cancer Symptom Index (FCSI-9): Reliability, validity, responsiveness, and clinical meaningfulness. The Oncologist; March 2010; 15: 308-316.
Tarantino MD, Mathias SD, Snyder CF, Isitt JJ, Gernsheimer T, Young J. Impact of ITP on workplace productivity and physician visits. Current Medical Research and Opinion, 2010; 26 (2), 319-328.
Mathias SD, Gao SK, Rutstein M, Snyder C, Wu A, Cella D. Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences. Current Medical Research and Opinion, 2009; 25 (2), 375-383.
Lewis QF, Lanneau MS, Mathias SD, Terrell DR, Vesely SK, George JN. Long-term abnormalities of health-related quality of life following recovery from thrombotic thrombocytopenic purpura. Transfusion, 2009; 49 (1), 118-124.
George JN, Mathias SD, Go RS, Guo M, Henry DH, Lyons R, Redner RL, Rice L, and Schipperus MR. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. British J of Hematology, 2009 Feb; 144 (3): 409-15.
Schwartzberg LS, Stepanski EJ, Walker MS, Mathias SD, Houts AC, Fortner BV. Implications of IV Monoclonal Antibody Infusion Reaction for the Patient, Caregiver, and Practice: Results of a Multicenter study. Supportive Care in Cancer, 2009 17(1); 91-98.
Leidy NK, Mathias SD, Parasuraman BM, Patrick DL, Pathak D. Development and validation of an onset of effect questionnaire for patients with asthma. Allergy Asthma Proc, September 4, 2008 Nov - Dec; 29 (6) 590-9.
Snyder CF, Mathias SD, Cella D, Isitt JJ, Wu AW, and Young J. Burden of illness of immune thrombocytopenic purpura: impact on health-related quality of life. Current Medical Research and Opinion, 2008. 24 (10); 2767-76.
Mathias SD, Gao SK, Miller KL. Cella D, Snyder C, Turner R, Wu, A, Bussel JB, George JN, McMillan R, Kholos Wysocki D, Nichol JL. Impact of chronic immune thrombocytopenic purpura (ITP) on health-related quality of life: a conceptual model starting with the patient's perspective. Health and Quality of Life Outcomes. 2008, 6:13.
Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL. A Disease-Specific Measure of Health-Related Quality of Life for Use in Adults with Chronic Immune Thrombocytopenic Purpura: Subsequent Validation within a Clinical Trial. Clinical Therapeutics. 2007 May; 29(5): 950-962.
Colwell HH, Mathias SD, Ngo NH, Gitlin M, Lu ZJ, Knoop T. The impact of infusion reactions on oncology patients and clinicians in the inpatient and outpatient practice settings: oncology nurses' perspective. J of Infusion Nursing. 2007 May/June; 30(3): 153-160.
Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health and Quality of Life Outcomes. 2007, 5:11.
Potter LP, Mathias SD, Raut M, Kianifard F, Tavakkol A, Landsman A. The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis. J of Derm Treatment. 2007, 18:46-52.
Potter LP, Mathias SD, Raut M, Kianifard F, Tavakkol A. The OnyCOE-t questionnaire: Responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis. Health and Quality of Life Outcomes. 2006, 4:50.
Colwell HH, Mathias SD, Cimms TA, Rothman M, Friedman AJ, Patrick DL. The ORTHO BC-SAT: a satisfaction questionnaire for women using hormonal contraceptives. Quality of Life Research. 2006, 15 (10): 1621-1631.
Mathias SD, Colwell HH, LoCoco JM, Karvois DL, Pritchard ML, Friedman AJ. ORTHO birth control satisfaction assessment tool: assessing sensitivity to change and predictors of satisfaction. Contraception. 2006, 74 (4): 303 - 308.
Colwell HH, Hunt BJ, Pasta DJ, Palo WA, Mathias SD, and Joseph-Ridge NJ. Gout Assessment Questionnaire: Initial Results of Reliability, Validity and Responsiveness. Int J of Clin Pract. 2006; Oct; 60(10): 1210-7.
Mathias SD, George JG, Aledort LA, Deuson RD, Giagoundis AG, Kessler CM, Kie KN, Rodeghiero RF. "Health-related Quality of Life (HRQOL) in chronic immune thrombocytopenia (ITP) patients: results from a long-term study of romiplostim." Presented at the European Hematology Association, London, England. June 2011.
Rummel M, Kuter D, Mandanas R, Giagounidis A, Coughlin P, Wang X, Mathias SD, Deuson R. "Patient Quality of Life in Nonsplenectomized Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim or Medical Standard of Care." Presented at the 52nd American Society of Hematology Annual Meeting. Orlando, Florida. December 2010.
Mathias SD, Crosby RD, Zazzali J. "Using Multiple Anchor and Distribution-based estimated to determine the Minimal Important Difference (MID) for the Urticaria Activity Score (UAS). " Presented at the I7th Annual Meeting of the International Society of Quality of Life (ISOQOL) Research. London, England. October 2010.
Mathias SD, Crosby RD, Qian Y, Chung K. "Estimating Minimally Important Difference (MID) for the worst pain rating of the Brief Pain Inventory (BPI) - short form (SF)." Presented at the American Society of Clinical Oncology. Chicago, Illinois, June 2010.
Blanchette V, Buchanan GR, Bomgaars L, Collier A, Bussel J, Klaassen RJ, Mathias SD, Deuson R. "Effect of romiplostim on parental burden and health-related quality of life (HRQoL) in children with chronic immune thrombocytopenia (ITP)." Presented at the American Society of Pediatric Hematology/Oncology. Montreal, Canada, April 2010.
Mathias SD, Rosen R, Kaplan A, Saina S, Spector S, Dreskin S, Sapra S. "Patient-reported morbidity and qualitative assessment of burden of illness in chronic idiopathic urticaria." Presented at the World Allergy Congress. Buenos Aires, Argentina: December 2009.
Sapra S, Rosen R, Kaplan A, Saina S, Spector S, Dreskin S, Mathias SD. "A Patient-reported outcome diary for chronic idiopathic urticaria: finalizing its contents based on findings from an interview study." Presented at the 16th Annual Meeting of the International Society of Quality of Life (ISOQOL) Research. New Orleans, Louisiana: October 2009.
Mathias SD, George J, Lyons R, Cuevas F, Go R, and Guo M. "Health-Related Quality of Life in Patients with Chronic Immune Thrombocytopenic Purpura: results from two placebo-controlled Phase 3 studies of romiplostim." Presented at MASCC Annual Symposium. Houston, Texas: June 2008.
Mathias SD, Tarantino M, Guo M, Gao, S. "Burden of Immune Thrombocytopenic Purpura (ITP) on Health-Related Quality of Life." Presented at the 13th Annual International Society for Pharmacoeconomics and Outcomes Research Congress. Toronto, Canada: May 2008.
Tarantino M, Henry D, Go R, Lefrere F, Lichtin A, Terebelo H, Viallard J, Mathias S, Deeter R, Nie K, and Nichol, J. "Health-Related Quality of Life in Patients with Chronic Immune Thrombocytopenic Purpura: interim results from an open-label study of AMG 531." Presented at American Society of Hematology. Orlando, Florida: December 2007.
Mathias SD, Traina S. "Evaluating patient-reported outcomes in ITP patients; a conceptual framework." Presented at the International Society of Quality of Life conference on PRO outcomes in clinical practice. Budapest, Hungary: June 2007.
Mathias SD, Deuson R, Traina S, Gao SK. "Quality of life in patients with myelodysplastic syndromes: a review of questionnaires assessing disease burden and treatment impact." Presented at the European Hematology Association meeting. Vienna, Austria: June 2007.
Schlumberger MJ, Sherman SI, Hoff AO, Baudin, Chung KC. Foreman AJ, Mathias SD, Miller DP, Stepan DE. "Diarrhea burden in medullary thyroid cancer patients: impact of motesanib diphosphate on diarrhea symptoms; interim results." Presented at the 2007 annual meeting of the endocrine society (ENDO). Toronto, Canada: June 2007.
Mink DR, Miller KL, Mathias SD. "Multiple methods to estimate the minimal clinically important difference of the ocular surface disease index." Presented at the ARVO 2007 annual meeting. Ft Lauderdale, Florida: May 2007.
Mathias SD, Parasuraman B, Petrillo J, Leidy NK. "Understanding Patient Perception of Therapy: development of a weekly diary to determine whether patients with asthma can feel their maintenance inhaler working right away." Presented at the 12th Annual International Society for Pharmacoeconomics and Outcomes Research Congress. Arlington, VA; May 2007.
Leidy NK, Patrick D, Parasuraman, Petrillo J, Mathias SD. " Can patients with asthma feel their maintenance inhaler working right away? Reproducibility and validity of a weekly diary for assessing perception and satisfaction." Presented at the 12th Annual International Society for Pharmacoeconomics and Outcomes Research Congress. Arlington, VA; May 2007
Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL. "Development and initial validation of the immune thrombocytopenic purpura patient assessment questionnaire (ITP-PAQ), a disease-specific health-related quality of life questionnaire." Presented at the American Society of Hematology annual meeting. Orlando, Florida: December 2006.
Miller KL, Mink DR, Mathias SD. "Estimating the minimal clinical important difference of the ocular surface disease index: preliminary findings. " Presented at the 13th Annual Meeting of the International Society of Quality of Life Research (ISOQOL). Lisbon, Portugal; October 2006.
Mathias SD, Colwell HH, Pritchard ML, Lu ZJ, Wright N. "Psychometric evaluation of a patient-reported outcome questionnaire for metastatic colorectal cancer." Presented at the 9th International Society for Pharmacoeconomics and Outcomes Research Congress. Copenhagen, Denmark; October 2006.
Bhattacharyya SK, Colwell HH, Mathias SD. "Impact of Infusion Reactions on Oncology Patients, Families and Clinic Staff." Presented at the American Psychosocial Oncology Society (APOS) 3rd Annual Conference. Amelia Island, Florida; February 2006.
When you select HOS to partner with you can be guaranteed to have a dedicated and experienced team fully committed to delivering quality work. HOS approaches each project strategically, and provides innovative and scientifically sound solutions and results.
FIND OUT MORE ABOUT HOS >